Reports
Sale
Global COVID-19 Diagnostics Market Size, Share, Growth: By Test Type: PCR Test, Antigen Test, Antibody Test, Others; By Product; By Sample Type; By Business Model: Point-of-Care (PoC) Testing, Non-Point-of-Care (PoC) Testing; By End Use; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; 2024-2032
Global COVID-19 Diagnostics Market Outlook
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States, which has performed around 390 million tests for COVID-19 as of March 2021.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Asia Pacific and North America to Significantly Aid the Demand Growth for COVID-19 Diagnostics
The large and growing number of coronavirus patients in nations, such as India, with a huge population base, is leading to a rapid increase in the demand for COVID-19 testing kits and diagnostic tools in the Asia Pacific region. The diagnostic facilities in the Asia Pacific have been witnessing a continuous expansion, with the government initiating mass testing programmes to tackle the pandemic. The implementation of various government initiatives, like the Indian government’s plan to expand the number of rapid action antigen kits for more rigorous detection of COVID-19, have been favourable for the growth of the COVID-19 diagnostics market.
North America is also substantially adding to the demand for COVID-19 testing kits and diagnostic tests, owing to the exorbitant number of active coronavirus patients in the United States. The United States and Canada have granted emergency use authorisation to COVID-19 diagnostic kits in order to expand the testing capacity. This has provided a further thrust to the growth of the COVID-19 diagnostics market.
COVID-19 Diagnostics: Market Segmentation
COVID-19 is a single-stranded RNA coronavirus that infects the respiratory system of the human body and is generally spread through the close contact with an infected patient by coughing or sneezing. COVID-19 diagnostics refer to the processes of analysing test samples to detect either the current or recent presence of SARS-CoV-2. The diagnostic kits detect the presence of the virus or antibodies produced in response to the infection.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
By test type, the market is segmented into:
- PCR Test
- Antigen Test
- Antibody Test
- Others
Based on product, the market is divided into the following:
- RT-PCR Assay Kits
- Immunoassay Test Strips
- Others
On the basis of sample type, the market is segmented into:
- Nasopharyngeal Swab
- Oropharyngeal (OP) Swab
- Nasal Swab
- Blood Test
- Others
By business model, the market is divided into:
- Point-of-Care (PoC) Testing
- Non-Point-of-Care (PoC) Testing
The end uses for the market are categorised into the following segments:
- Hospitals
- Diagnostic Centres and Clinics
- Laboratories
- Others
The regional markets for the COVID-19 diagnostics market can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Growing Technological Advancements to Boost the COVID-19 Diagnostics Market Growth
The introduction of new and improved technology has helped in the active detection of coronavirus patients and checked the uncontrolled growth of infections across the world. The key players in the market have invested heavily to produce better COVID-19 testing and diagnostic kits, with improved accuracy and lower time of testing, further propelling the growth of the market. The surge of the second wave of the coronavirus pandemic around the world has alerted governments of different nations and increased the testing to better control the virus, thus, catalysing the growth of the market. The increasing initiation of drive-in and walk-through testing centres, which have made the process of testing convenient, have also accelerated the market growth for COVID-19 diagnostics.
Key Players in the Global COVID-19 Diagnostics Market
The report gives a detailed analysis of the following key players in the global COVID-19 diagnostics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- F. Hoffmann-La Roche Ltd
- Abbott Laboratories
- Thermo Fisher Scientific Inc
- Guangzhou Wondfo Biotech Co., Ltd.
- Altona Diagnostics GmbH
- Mylab Discovery Solutions Pvt. Ltd.
- Others
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Test Type |
|
| Breakup by Product |
|
| Breakup by Sample Type |
|
| Breakup by Business Model |
|
| Breakup by End Use |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global COVID-19 Overview
8.1 Global Number of COVID-19 Cases
8.2 Global COVID-19 Cases by Region
8.2.1 North America
8.2.2 Europe
8.2.3 Asia Pacific
8.2.4 Latin America
8.2.5 Middle East and Africa
9 Global COVID-19 Diagnostics Market Analysis
9.1 Key Industry Highlights
9.2 Global COVID-19 Diagnostics Market (2020-2026)
9.3 Global COVID-19 Diagnostics Market by Test Type (2020-2026)
9.3.1 PCR Test
9.3.2 Antigen Test
9.3.3 Antibody Test
9.3.4 Others
9.4 Global COVID-19 Diagnostics Market by Product (2020-2026)
9.4.1 RT-PCR Assay Kits
9.4.2 Immunoassay Test Strips
9.4.3 Others
9.5 Global COVID-19 Diagnostics Market by Sample Type (2020-2026)
9.5.1 Nasopharyngeal Swab
9.5.2 Oropharyngeal (OP) Swab
9.5.3 Nasal Swab
9.5.4 Blood Test
9.5.5 Others
9.6 Global COVID-19 Diagnostics Market by Business Model (2020-2026)
9.6.1 Point-of-Care (PoC) Testing
9.6.2 Non-Point-of-Care (PoC) Testing
9.7 Global COVID-19 Diagnostics Market by End Use (2020-2026)
9.7.1 Hospitals
9.7.2 Diagnostic Centres and Clinics
9.7.3 Laboratories
9.7.4 Others
9.8 Global COVID-19 Diagnostics Market by Region (2020-2026)
9.8.1 North America
9.8.1.1 United States of America
9.8.1.2 Canada
9.8.2 Europe
9.8.2.1 United Kingdom
9.8.2.2 Germany
9.8.2.3 France
9.8.2.4 Spain
9.8.2.5 Others
9.8.3 Asia Pacific
9.8.3.1 China
9.8.3.2 Japan
9.8.3.3 India
9.8.3.4 ASEAN
9.8.3.5 Australia
9.8.3.6 Others
9.8.4 Latin America
9.8.4.1 Brazil
9.8.4.2 Argentina
9.8.4.3 Mexico
9.8.4.4 Others
9.8.5 Middle East and Africa
9.8.5.1 Saudi Arabia
9.8.5.2 United Arab Emirates
9.8.5.3 Nigeria
9.8.5.4 South Africa
9.8.5.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Competitive Landscape
11.1 Market Structure
11.2 Company Profiles
11.2.1 F. Hoffmann-La Roche Ltd
11.2.1.1 Company Overview
11.2.1.2 Product Portfolio
11.2.1.3 Demographic Reach and Achievements
11.2.1.4 Certifications
11.2.2 Abbott Laboratories
11.2.2.1 Company Overview
11.2.2.2 Product Portfolio
11.2.2.3 Demographic Reach and Achievements
11.2.2.4 Certifications
11.2.3 Thermo Fisher Scientific Inc
11.2.3.1 Company Overview
11.2.3.2 Product Portfolio
11.2.3.3 Demographic Reach and Achievements
11.2.3.4 Certifications
11.2.4 Guangzhou Wondfo Biotech Co., Ltd.
11.2.4.1 Company Overview
11.2.4.2 Product Portfolio
11.2.4.3 Demographic Reach and Achievements
11.2.4.4 Certifications
11.2.5 Altona Diagnostics GmbH
11.2.5.1 Company Overview
11.2.5.2 Product Portfolio
11.2.5.3 Demographic Reach and Achievements
11.2.5.4 Certifications
11.2.6 Mylab Discovery Solutions Pvt. Ltd.
11.2.6.1 Company Overview
11.2.6.2 Product Portfolio
11.2.6.3 Demographic Reach and Achievements
11.2.6.4 Certifications
11.2.7 Others
12 Industry Events and Developments
List of Key Figures and Tables
1. Global COVID-19 Cases by Region
2. Global COVID-19 Diagnostics Market: Key Industry Highlights, 2020 and 2026
3. Global COVID-19 Diagnostics Market: Breakup by Test Type (USD Billion)
4. Global COVID-19 Diagnostics Market: Breakup by Product (USD Billion)
5. Global COVID-19 Diagnostics Market: Breakup by Sample Type (USD Billion)
6. Global COVID-19 Diagnostics Market: Breakup by Business Model (USD Billion)
7. Global COVID-19 Diagnostics Market: Breakup by End Use (USD Billion)
8. Global COVID-19 Diagnostics Market: Breakup by Region (USD Billion)
9. North America COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
10. Europe COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
11. Asia Pacific COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
12. Latin America COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
13. Middle East and Africa COVID-19 Diagnostics Market: Breakup by Country (USD Billion)
14. Global COVID-19 Diagnostics Market Structure
Key Questions Answered in the Report
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which have performed nearly 390 million tests for COVID-19 as of March 2021.
The major drivers of the market, such as the growing number of COVID-19 cases, favourable government policies, and growing investments into streamlining the diagnostic process, are aiding the market growth.
The key trends guiding the growth of the market include the growing technological advancements and increasing R&D activities.
The major regions in the market are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The significant test types available in the market are PCR test, antigen test, and antibody test, among others.
The major products available in the market are RT-PCR assay kits and immunoassay test strips, among others.
The major sample types available in the market are nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others.
The significant business models in the market are point-of-care (PoC) testing and non-point-of-care (PoC) testing.
The significant end use sectors in the market are hospitals, and diagnostic centres and clinics, laboratories, among others.
The major players in the market are F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, Guangzhou Wondfo Biotech Co., Ltd., Altona Diagnostics GmbH, and Mylab Discovery Solutions Pvt. Ltd., among others.
Analyst Review
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed about 390 million tests for COVID-19 as of March 2021. The market is further being driven by the growing R&D investments by the key players and the governments globally.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the market. Based on its test types, the COVID-19 diagnostics market can be segmented into PCR test, antigen test, and antibody test, among others. On the basis of products, the market is divided into RT-PCR assay kits and immunoassay test strips, among others. By sample types, the market is categorised into nasopharyngeal swab, oropharyngeal (OP) swab, nasal swab, and blood test, among others. On the basis of business models, the market is segmented into point-of-care (PoC) testing and non-point-of-care (PoC) testing. Based on end uses, the market is segregated into hospitals, diagnostic centres and clinics, and laboratories, among others. The major regional markets for COVID-19 diagnostics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Thermo Fisher Scientific Inc, Guangzhou Wondfo Biotech Co., Ltd., Altona Diagnostics GmbH, and Mylab Discovery Solutions Pvt. Ltd., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER